Skip to content

Opaleye Management Inc., 10% owner at Eton Pharmaceuticals, sold ETON on Jul 14, 2026

Data as of Oct 16

▼ SELL$563K15,000 shares at $37.54Opaleye Management Inc. 10% ownerETON Eton Pharmaceuticals, Inc.
Watch ETON
Traded
Jul 14, 2026
Disclosed
Jul 16, 2026
Filed
2 days after the trade

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

Opaleye Management Inc., 10% owner at Eton Pharmaceuticals, sold ETON on Jul 14, 2026TRADEDDISCLOSED
ETONSimilar stocks (XLV — its sector index fund), rebased to ETON's price on the disclosure day
ETON since disclosure
+35.3%
after the sale
Similar stocks (XLV) since disclosure
+9.2%
XLV — its sector index fund

Change in closing price from Jul 16, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

Other trades in the same filing

  1. ▼ SELLOpaleye Management Inc. 10% ownerETON Eton Pharmaceuticals, Inc.$500Kdisclosed Jul 16 · filed 2 days after the trade

See every trade on ETON →